Healthcare provider profile · identity verified

Michael A Reed, DO

Family Practice · ATHENS, OH · NPI 1871511873

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Oxycodone Hcl	Oxycodone Hcl	577	64
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	522	61
Gabapentin	Gabapentin	278	52
Alprazolam	Alprazolam	228	27
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	223	31
Omeprazole	Omeprazole	207	31
Levothyroxine Sodium	Levothyroxine Sodium	184	20
Atorvastatin Calcium	Atorvastatin Calcium	174	34
Trazodone Hcl	Trazodone Hcl	170	38
Morphine Sulfate Er	Morphine Sulfate	127	16
Amlodipine Besylate	Amlodipine Besylate	115	24
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	110	15
Albuterol Sulfate Hfa	Albuterol Sulfate	107	29
Lisinopril	Lisinopril	106	22
Lorazepam	Lorazepam	106	46
Mirtazapine	Mirtazapine	101	21
Escitalopram Oxalate	Escitalopram Oxalate	93	17
Citalopram Hbr	Citalopram Hydrobromide	90	13
Metoprolol Tartrate	Metoprolol Tartrate	86	15
Fentanyl	Fentanyl	85	suppressed
Xarelto	Rivaroxaban	82	suppressed
Diazepam	Diazepam	81	14
Pregabalin	Pregabalin	81	12
Metoprolol Succinate	Metoprolol Succinate	80	20
Furosemide	Furosemide	78	24
Bupropion Xl	Bupropion Hcl	74	12
Donepezil Hcl	Donepezil Hcl	74	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	72	15
Clonazepam	Clonazepam	71	suppressed
Morphine Sulfate	Morphine Sulfate	70	40
Duloxetine Hcl	Duloxetine Hcl	68	14
Potassium Chloride	Potassium Chloride	65	14
Spironolactone	Spironolactone	63	suppressed
Cefdinir	Cefdinir	61	27
Pantoprazole Sodium	Pantoprazole Sodium	60	14
Ropinirole Hcl	Ropinirole Hcl	59	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	58	suppressed
Tizanidine Hcl	Tizanidine Hcl	58	17
Quetiapine Fumarate	Quetiapine Fumarate	56	suppressed
Memantine Hcl	Memantine Hcl	54	suppressed
Glimepiride	Glimepiride	51	12
Montelukast Sodium	Montelukast Sodium	47	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	46	13
Sertraline Hcl	Sertraline Hcl	46	suppressed
Celecoxib	Celecoxib	45	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	44	11
Metformin Hcl	Metformin Hcl	44	suppressed
Methadone Hcl	Methadone Hcl	44	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	43	suppressed
Famotidine	Famotidine	41	suppressed
Eliquis	Apixaban	38	suppressed
Fluticasone Propionate	Fluticasone Propionate	38	15
Losartan Potassium	Losartan Potassium	37	suppressed
Ondansetron Hcl	Ondansetron Hcl	37	suppressed
Jardiance	Empagliflozin	36	suppressed
Ondansetron Odt	Ondansetron	36	14
Promethazine Hcl	Promethazine Hcl	35	suppressed
Tramadol Hcl	Tramadol Hcl	34	suppressed
Butorphanol Tartrate	Butorphanol Tartrate	33	suppressed
Warfarin Sodium	Warfarin Sodium	33	suppressed
Allopurinol	Allopurinol	31	suppressed
Prednisone	Prednisone	31	16
Zolpidem Tartrate	Zolpidem Tartrate	31	suppressed
Alendronate Sodium	Alendronate Sodium	29	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	28	suppressed
Clopidogrel	Clopidogrel Bisulfate	27	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	25	suppressed
Baclofen	Baclofen	24	suppressed
Levetiracetam	Levetiracetam	24	suppressed
Lubiprostone	Lubiprostone	24	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	24	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	23	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	23	suppressed
Diclofenac Sodium	Diclofenac Sodium	22	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	22	suppressed
Meclizine Hcl	Meclizine Hcl	21	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	20	suppressed
Azithromycin	Azithromycin	19	15
Dicyclomine Hcl	Dicyclomine Hcl	19	suppressed
Linzess	Linaclotide	19	suppressed
Metformin Hcl Er	Metformin Hcl	19	suppressed
Oxycontin	Oxycodone Hcl	19	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	18	suppressed
Testosterone Cypionate	Testosterone Cypionate	18	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	17	suppressed
Bumetanide	Bumetanide	17	suppressed
Np Thyroid	Thyroid,pork	17	suppressed
Pravastatin Sodium	Pravastatin Sodium	17	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	16	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	16	13
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	16	suppressed
Mounjaro	Tirzepatide	16	suppressed
Penicillin V Potassium	Penicillin V Potassium	16	suppressed
Cephalexin	Cephalexin	15	11
Isosorbide Mononitrate Er	Isosorbide Mononitrate	15	suppressed
Mupirocin	Mupirocin	15	suppressed
Carvedilol	Carvedilol	14	suppressed
Dexamethasone	Dexamethasone	14	suppressed
Finasteride	Finasteride	14	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	14	suppressed
Novolin R	Insulin Regular, Human	14	suppressed
Olanzapine	Olanzapine	14	suppressed
Propranolol Hcl	Propranolol Hcl	14	suppressed
Atenolol	Atenolol	13	suppressed
Methocarbamol	Methocarbamol	13	suppressed
Nitroglycerin	Nitroglycerin	13	suppressed
Nystatin	Nystatin	13	suppressed
Potassium Citrate Er	Potassium Citrate	13	suppressed
Spiriva Respimat	Tiotropium Bromide	13	suppressed
Valacyclovir	Valacyclovir Hcl	13	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	12	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	12	suppressed
Farxiga	Dapagliflozin Propanediol	12	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	12	suppressed
Fondaparinux Sodium	Fondaparinux Sodium	12	suppressed
Irbesartan	Irbesartan	12	suppressed
Meloxicam	Meloxicam	12	suppressed
Simvastatin	Simvastatin	12	suppressed
Amiodarone Hcl	Amiodarone Hcl	11	suppressed
Constulose	Lactulose	11	suppressed
Januvia	Sitagliptin Phosphate	11	suppressed
Lovastatin	Lovastatin	11	suppressed
Topiramate	Topiramate	11	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error